FIELD: medicine.
SUBSTANCE: invention may be used in PCR diagnostics for medical purposes.
EFFECT: reduced length of multiplex PCR with no increase of the Taq-polymerase concentration, with avoided false results caused by the different concentrations of nucleotide target sequences.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MULTIPLEX PCR-ANALYSIS AND SET FOR ITS REALISATION | 2012 |
|
RU2496883C1 |
DEVICE FOR POLYMERASE CHAIN REACTION | 2013 |
|
RU2535333C1 |
DOSAGE FORM FOR AMPLIFICATION OF NUCLEIC ACIDS | 2020 |
|
RU2729223C1 |
OLIGONUCLEOTIDES FOR DETECTION OF 22FA SEROTYPE OF STREPTOCOCCUS PNEUMONIAE | 2021 |
|
RU2802203C2 |
REAGENT KIT FOR CHLAMYDIA TRACHOMATIS DNA DETECTION AND ITS APPLICATION | 2014 |
|
RU2621863C2 |
OLIGONUCLEOTIDES FOR DETECTION OF 12FAB SEROTYPE OF STREPTOCOCCUS PNEUMONIAE | 2021 |
|
RU2795021C1 |
DIAGNOSTIC TECHNIQUE FOR HUMAN OR SIMIAN CHLAMIDIA INFECTION AND KIT FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2385946C1 |
OLIGONUCLEOTIDES FOR DETECTION OF 8 SEROTYPE OF STREPTOCOCCUS PNEUMONIAE | 2021 |
|
RU2802081C2 |
SET OF SYNTHETIC OLIGONUCLEOTIDES FOR DETECTING CORONAVIRUS RNA | 2021 |
|
RU2750564C1 |
SET OF SYNTHETIC OLIGONUCLEOTIDES FOR DETECTING CORONAVIRUS RNA | 2021 |
|
RU2761025C1 |
Authors
Dates
2012-12-27—Published
2011-11-25—Filed